glp-1 fatty liver disease Why are agonists being used to treat patients with nonalcoholic disease? Fatty Liver Disease: How GLP-1

Conclusion Emerging evidence underscores the cardioprotective effects of GLP-1RAs, which make them potentially useful for different subpopulations of patients with cardiovascular diseases, including those with HFpEF

GLP1 receptor agonists and the path to sustainable obesity care

Although the number of beige adipocytes did not increase, they displayed a more thermogenic phenotype characterized by smaller LDs, elevated expression of uncoupling protein 1 ( UCP1 ) and HSL , and enhanced glucose utilization, all features consistent with increased mitochondrial uncoupling and browning

Rarer issues like gallstones, pancreatitis, or gastroparesis can happen, though

The complications can include: Long-lasting depressive symptoms, potentially years after usage Male breast enlargement (gynecomastia) which may need surgical removal Increased and potentially irreversible hair growth in women (hirsutism) The formation of liver tumors If steroids are injected, theres a risk of contracting serious diseases like HIV or Hepatitis C Heart muscle disease (cardiomyopathy) Every steroid usage carries its risks and potential harm, and these listed are some of the most severe ones